Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
A team of University of Wisconsin-Madison researchers have found a way to revive dying brain cells in lab mice, spurring hopes of combating major human neurological diseases.
In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease.
A gift of $500,000 from George E. Prescott, a member of the Waisman Center's board of visitors, will benefit the Parkinson's disease research program at the Waisman Center.
By pumping a potent growth factor directly into the human brain, an international team of scientists and surgeons has demonstrated significant remediation of the debilitating symptoms of patients with Parkinson’s disease.
